Cargando…

Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era

Detalles Bibliográficos
Autores principales:	Nicholas, Jacqueline A., Shin, Robert K, Alvarez, Enrique, Hendin, Barry, Nair, Kavita V., Lublin, Fred D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832784/ https://www.ncbi.nlm.nih.gov/pubmed/33486401 http://dx.doi.org/10.1016/j.msard.2020.102715

Ejemplares similares

Mental health in the post-COVID-19 era: challenges and the way forward
por: Vadivel, Ramyadarshni, et al.
Publicado: (2021)

Trauma surgery in the era of monkeypox: Evidence, priorities and the way forward – Correspondence
por: Afif, Sadaf, et al.
Publicado: (2022)

Relapsing experimental allergic encephalomyelitis an autoimmune model of multiple sclerosis
por: Lublin, Fred D.
Publicado: (1985)

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
por: Cohan, Stanley L., et al.
Publicado: (2021)

Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
por: Shin, Robert K., et al.
Publicado: (2021)

That Epidemic of Experts
por: West, G. S.
Publicado: (1898)

Multiple Sclerosis Phenotypes as a Continuum: The Role of Neurologic Reserve
por: Vollmer, Timothy L., et al.
Publicado: (2021)

Perspectives and lessons from the Philippines’ decades-long battle with dengue
por: Ong, Erika P., et al.
Publicado: (2022)

High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
por: Freeman, Léorah, et al.
Publicado: (2022)

Emergency Medical Care of Multiple Sclerosis Patients: Primary Data from the Mount Sinai Resource Utilization in Multiple Sclerosis Project
por: Oynhausen, Svenja, et al.
Publicado: (2014)

Learning from challenges to maternal health during COVID Era; Perspective from Pakistan
por: Fazal, Faizan, et al.
Publicado: (2022)

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
por: Vollmer, Brandi L., et al.
Publicado: (2018)

Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment
por: Vollmer, Brandi L., et al.
Publicado: (2020)

Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis
por: Kashoo, Faizan Z., et al.
Publicado: (2020)

Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, Canada
por: Solomon, Jacqueline M., et al.
Publicado: (2022)

Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience
por: Vollmer, Brandi, et al.
Publicado: (2017)

The 2013 clinical course descriptors for multiple sclerosis: A clarification
por: Lublin, Fred D., et al.
Publicado: (2020)

The Plague Problem Restated with Some Expert Errors
por: Thomson, Geo. S.
Publicado: (1900)

Medical Witnesses Shall Receive Compensation as Experts
por: White, James P.
Publicado: (1878)

Marine invasions enter the genomic era: three lessons from the past, and the way forward
por: Viard, Frédérique, et al.
Publicado: (2016)

Research output of Arab students: The way forward
por: Alamri, Yassar
Publicado: (2016)

COVID-19 Pandemic: The Way Forward – Correspondence
por: Vijayasekaran, D., et al.
Publicado: (2020)

Home Vaccination - The way forward in a Pandemic
por: Kumar, R. Kishore
Publicado: (2021)

The way forward for drug-resistant tuberculosis in the Philippines
por: Bernardo, Madeleine Nicole G, et al.
Publicado: (2022)

Patient-reported outcomes in multiple sclerosis: Validation of the Quality of Life in Neurological Disorders (Neuro-QoL™) short forms
por: Medina, Luis D, et al.
Publicado: (2019)

The Medical Expert—What He Is and What He Should Be
por: Hagan, Hugh
Publicado: (1897)

Expert consensus on the management of chronic lymphocytic leukaemia in Asia
por: Tse, Eric, et al.
Publicado: (2023)

The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity
por: Hendin, Barry, et al.
Publicado: (2023)

Medical service fees – a key step forward
por: Jiao, Wei-Ping
Publicado: (2019)

Whither the Bicarbonate Era
por: Swenson, Erik R.
Publicado: (2020)

Alemtuzumab in Covid era
por: Iovino, Aniello, et al.
Publicado: (2021)

Adermatoglyphia in the Era of Biometrics
por: De, Abhishek, et al.
Publicado: (2022)

Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Characteristics of COVID-19 disease in multiple sclerosis patients
por: Barzegar, Mahdi, et al.
Publicado: (2020)

Multiple Manifestations of Systemic Sclerosis Affect Walk Distance
por: Andréasson, Kristofer, et al.
Publicado: (2021)

Cancer and fertility preservation: international recommendations from an expert meeting
por: Lambertini, Matteo, et al.
Publicado: (2016)

A Bill to Regulate the Employment of, and Pay for, Medical Expert Testimony
por: Terrell, Henry W.
Publicado: (1897)

Cannabis and Multiple Sclerosis—The Way Forward
por: Rudroff, Thorsten, et al.
Publicado: (2017)

WHO declares the end of the COVID-19 global health emergency: lessons and recommendations from the perspective of ChatGPT/GPT-4
por: Cheng, Kunming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h3qbhnvsrnqp6qebo7ol9s1hmc